Key Drivers
- Strong liquidity
- Softer margins
- Moderate leverage
AIAI Summary
AptarGroup has shifted from a dependable defensive compounder to a “show-me” story: investors should wait for two more quarters of margin stabilization and a smooth CEO handoff before expecting a re-rating, because current profitability pressure and the broken 118–121 support zone leave the stock vulnerable despite solid cash generation.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong liquidity
- •Softer margins
- •Moderate leverage
ATR remains fundamentally solid, with strong liquidity, moderate leverage, and healthy cash generation, but softer recent margins and a fair-to-rich valuation limit near-term upside.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support test
- •Weak momentum
ATR closed at the bottom of its last month's range, confirming a clear downtrend after a roughly 12% decline, with support at $114-$118 and resistance at $120-$126 until price reclaims $120-$121.
Price broke below the $118-$121 area after 2026-05-08, extending a ~12% slide from $130.12 to $114.67
Sentiment & News
Key News Insights:
- •Earnings Beat
- •Margin Pressure
- •Research Update
AptarGroup beat Q1 expectations but saw lower profit and margin pressure with the stock sliding, while other ATR names added access-expansion and preclinical research updates.
Mixed-to-negative impact overall, as AptarGroup's strong top-line results were offset by weaker profitability and market skepticism
Similar Companies in Healthcare
Other companies in the same sector with AI ratings